Clinical Trials Directory

Trials / Completed

CompletedNCT01219569

Effects of Sevoflurane and Propofol on Light Flashed Evoked Pupillometry

The Effects of Sevoflurane and Propofol on Light Flashed Evoked Pupillometry

Status
Completed
Phase
Study type
Observational
Enrollment
35 (actual)
Sponsor
Rutgers, The State University of New Jersey · Academic / Other
Sex
All
Age
18 Years – 70 Years
Healthy volunteers
Not accepted

Summary

This is a study to focus on the feasibility of using a monitor which may signal loss of visual function intraoperatively.

Detailed description

The degree of a relative afferent pupillary defect (RAPD) has been correlated with the severity of an eye injury and has been shown to have prognostic significance as an indicator of retinal ischemia. Therefore light flashed evoked pupillometry (LFEP) may serve as a useful indicator of visual function. LFEP's are not known to be sensitive to anesthetics. We will measure LFEP's using different anesthetic techniques to see if there are measurable differences in the latency, amplitude and constriction velocity of the pupillary reflex. Prior to induction of anesthesia, pupillometer readings will be taken in the supine position in both eyes. The patient will be anesthetised using a standard induction technique. For maintenance of anesthesia a remifentanil infusion will be administered and supplemented by either propofol infusion (at 120 and 160 mcg/kg/min)or sevoflurane (at 1.5 and 2.5% end-tidal in random sequence. The patients will receive muscle relaxants as needed. Pupillometry readings will be taken in both eyes after induction, after steady maintenance has been achieved and every 10 minutes for 30 minutes at each drug dose.

Conditions

Interventions

TypeNameDescription
DRUGpropofolPropofol infusion 120 and 160 mcg/kg/min in random sequence during the operative procedure
DRUGSevofluranesevoflurane 1.5% and 2.5% end tidal in random sequence

Timeline

Start date
2007-08-01
Primary completion
2010-01-01
Completion
2010-01-01
First posted
2010-10-13
Last updated
2015-04-24

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT01219569. Inclusion in this directory is not an endorsement.